Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 May;8(5):e639-e640.
doi: 10.1016/S2214-109X(20)30114-5. Epub 2020 Mar 19.

Use of antiviral drugs to reduce COVID-19 transmission

Oriol Mitjà  1 , Bonaventura Clotet  2
Affiliations
Comment

Use of antiviral drugs to reduce COVID-19 transmission

Oriol Mitjà et al. Lancet Glob Health. 2020 May.
No abstract available

PubMed Disclaimer

Comment on

  • Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts.
    Hellewell J, Abbott S, Gimma A, Bosse NI, Jarvis CI, Russell TW, Munday JD, Kucharski AJ, Edmunds WJ; Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group; Funk S, Eggo RM. Hellewell J, et al. Lancet Glob Health. 2020 Apr;8(4):e488-e496. doi: 10.1016/S2214-109X(20)30074-7. Epub 2020 Feb 28. Lancet Glob Health. 2020. PMID: 32119825 Free PMC article.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hellewell J, Abbott S, Gimma A. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob Health. 2020 doi: 10.1016/S2214-109X(20)30074-7. published February 28. - DOI - PMC - PubMed
    1. Qifang Bi, Yongsheng Wu, Shujiang Mei. Epidemiology and transmission of COVID-19 in Shenzhen China: analysis of 391 cases and 1286 of their close contacts. medRxiv. 2020 doi: 10.1101/2020.03.03.20028423. published online March 4. (preprint). - DOI - PMC - PubMed
    1. Welliver R, Monto AS, Carewicz O. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA. 2001;285:748–754. - PubMed
    1. Yao X, Ye F, Zhang M. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa237. published online March 9. - DOI - PMC - PubMed
    1. Tett SE, Cutler DJ, Day RO, Brown KF. Bioavailability of hydroxychloroquine tablets in healthy volunteers. Br J Clin Pharmacol. 1989;27:771–779. - PMC - PubMed

Substances